The global demand for Nefopam Hydrochloride Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022 - 2028. Regarding volume, the market was calculated XX Ton in 2021 and forecast to touch XX Ton by 2028 with a CAGR of XX% during 2022-2028.
Nefopam, also known as Acupan, is a centrally acting, non-opioid painkilling medicine that is generally used to treat moderate to severe pain. Nefopam helps prevent shivering during surgery and in recovering from surgery. In addition, nefopam is used to treat severe hiccups. Because nefopam has fewer adverse effects, does not cause respiratory depression, and has a lower abuse potential, it can be used as an alternative to opioid analgesics or an adjuvant treatment in conjunction with opioids or other analgesics. Nefopam relieves pain in the brain and spinal cord through two unique mechanisms: antinociceptive effects from triple monoamine reuptake inhibition and antihyperalgesic activity via glutamatergic transmission regulation.
Market Dynamics
Lifestyle changes, lack of physical activity, and the increased number of surgical operations contribute to increased pain and related ailments worldwide, simultaneously increasing the demand for painkilling drugs. The increased demand is likely to promote the growth of the nefopam market. Non-opioids painkillers are being used as a substitute for opioid painkillers due to the opioid crisis and a reduction in opioid painkiller prescriptions. This is anticipated to expand the demand for non-opioid pain killers, hence, supplementing the growth of the nefopam hydrochloride market. Technological advancements will improve the product's performance, further contributing to the market's growth. The sudden pandemic has affected the supply of nefopam hydrochloride due to imposed restrictions, consequently hampering the market growth.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of nefopam hydrochloride. The growth and trends of Nefopam Hydrochloride Industry provide a holistic approach to this study.
Market Segmentation
This section of the nefopam hydrochloride market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Less Than 98%
- 98% To 99%
- More Than 99%
By Application
- Postoperative Analgesia
- Treatment Of Visceral Smooth Muscle Colic
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Nefopam Hydrochloride market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Nefopam Hydrochloride Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the nefopam hydrochloride market include Biosynth Carbosynth, Targetmol, Merck, Carbone Science, 3B Scientific, TCI, MedChemExpress, Vesino Industrial Co., Ltd., Achemtek, BOC Sciences, and J&K Scientific. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.